 |
|
|
|
|
 |
Last Updated: Sep 13, 2008 - 5:00:44 PM |
Latest Research
:
Infectious Diseases
:
Anthrax
Monoclonal antibody recognizes a specific sugar on the surface of anthrax bacteria spores
Spores of the dreaded Bacillus anthracis have already been used as a bioweapon against the civilian population. Once inhaled, the anthrax pathogen almost always leads to death if the victims are not treated within 24 to 48 hours. Rapid and accurate diagnosis is thus vital. A team from the Swiss Federal Institute of Technology (ETH) in Zürich, the Swiss Tropical Institute, and the University of Bern has now developed a new immunological approach that can be used to specifically recognize anthrax spores.
Aug 18, 2006 - 6:47:00 PM
|
Latest Research
:
Infectious Diseases
:
Anthrax
Scientists design functionalized liposome - a potent anthrax toxin inhibitor
Scientists funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), have engineered a powerful inhibitor of anthrax toxin that worked well in small-scale animal tests. Led by NIAID grantees Ravi S. Kane, Ph.D., of Rensselaer Polytechnic Institute, in Troy, NY, and Jeremy Mogridge, Ph.D., of the University of Toronto, the investigators built a fatty bubble studded with small proteins that can cling tightly to the cell membrane receptor-binding protein used by anthrax toxin to gain entry into a host cell.
Apr 25, 2006 - 9:20:00 PM
|
Latest Research
:
Infectious Diseases
:
Anthrax
PlyPH protein kills anthrax bacteria by exploding their cell walls
Not all biological weapons are created equal. They are separated into categories A through C, category A biological agents being the scariest: They are easy to spread, kill effectively and call for special actions by the pubic health system. One of these worrisome organisms is anthrax, which has already received its fair share of media attention. But work in Vince Fischettis laboratory at Rockefeller University suggests that a newly discovered protein could be used to fight anthrax infections and even decontaminate areas in which anthrax spores have been released.
Apr 22, 2006 - 5:43:00 PM
|
Latest Research
:
Infectious Diseases
:
Anthrax
Surprising new insights about the acid pH levels required for anthrax toxin
Surprising new insights about the acid pH levels required for anthrax toxin to invade the cells of the body may help accelerate development of medications for the treatment of anthrax, a disease caused by a spore-forming bacterium.
Sep 7, 2005 - 8:11:00 AM
|
Latest Research
:
Infectious Diseases
:
Anthrax
Diagnostic method for identifying Bacillus anthracis receives FDA approval
A method for identifying Bacillus anthracis, the causative agent of anthrax, has been cleared for diagnostic use by the U.S. Food and Drug Administration (FDA). The test, known as the Gamma Phage Assay, was modified by scientists at the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) to improve its performance and reliability when used with clinical specimens. The original form of the Gamma Phage Assay was first developed by the Centers for Disease Control and Prevention (CDC) in the mid-1950s.
Aug 30, 2005 - 8:56:00 PM
|
Latest Research
:
Infectious Diseases
:
Anthrax
Protective Antigen Ion Channel Asymmetric Blockade To Detect Anthrax Infection
A new laboratory method for quickly detecting active anthrax proteins within an infected blood sample at extremely low levels has been developed by researchers at the National Institute of Standards and Technology (NIST), the U.S. Army Medical Research Institute of Infectious Diseases and the National Cancer Institute.
Aug 29, 2005 - 10:04:00 PM
|
Latest Research
:
Infectious Diseases
:
Anthrax
ABthrax(TM) Safe and Effective against Anthrax
Human Genome Sciences, Inc. (HGSI) announced today that results published in the current issue of Clinical Infectious Diseases demonstrate that the first investigational agent against anthrax infection to be evaluated in a clinical study since the 2001 anthrax attacks in the United States, is safe, well tolerated and achieves the blood levels predicted by relevant animal models as necessary to afford significant protection from the lethal effects of the anthrax toxin.
Jul 25, 2005 - 11:13:00 AM
|
Latest Research
:
Infectious Diseases
:
Anthrax
DNI - Newly Identified Inhibitor of Anthrax Toxin May Contribute to Postexposure Therapy
A newly identified inhibitor of the anthrax toxin may be used to develop a safer and more effective vaccine and act as a therapeutic agent after exposure say researchers from Massachusetts and Germany. Their findings appear in the June 2005 issue of the journal Infection and Immunity.
Jun 20, 2005 - 4:08:00 PM
|
<< prev
next >>
|
|
|
|
| Health |
Do you know if your blood pressure is high?
|
Incubator care at birth reduces depression risk in adult life
|
Kids safe and secure with grandparents around
|
Shed tears to stay healthy
|
1918 Spanish flu records could hold the key to solving future pandemics
|
Listening to classical music may reduce pregnancy stress
|
Most women don't find sexual problems upsetting: Survey
|
Pneumococcal vaccine could prevent numerous deaths, save costs during a flu pandemic, model predicts
|
Breast milk provides baby molecule to build immunity
|
Vaccinating family members protects newborns from flu
|
| | Healthcare |
India, China revive ties in medicine in memory of Kotnis
|
Myanmar faces 24,000 AIDS deaths for lack of ART drugs
|
Malnutrition downplaying India's economic growth: UN
|
India building five blood banks of world standard: Ramados
|
Plan to Start MBBS Courses in IITs not feasible
|
Mid-day meal: 10 schools face action for irregularities
|
Nearly Half of Primary Care Doctors in US Would Like to Quit
|
I aborted after cops pushed me: Sister of absconding doctor
|
Prioritise sanitation in development process: PM
|
Israeli couple makes news, but Indians reluctant on surrogacy
|
| | Latest Research |
Combining patient photos with imaging improves diagnosis
|
An ace for visually-impaired students in computer science
|
Rivers are carbon processors, not inert pipelines
|
Symptoms of depression associated with increase in abdominal fat
|
Psychiatric disorders common among college-age individuals; few seek treatment
|
Delays in radiation therapy lead to increased breast cancer recurrence
|
U of Minnesota Institute on Race and Poverty reports dismal results for charter schools
|
PA-824 : Promising new drug for TB
|
New screening strategy increases Down's syndrome detection before birth
|
Clear advantage of high efficacy Haemodiafiltration over conventional hemodialysis
|
| | Medical News |
India, China revive ties in medicine in memory of Kotnis
|
Disabled stage mass protest at India Gate
|
Dasmunsi continues to be on life support system
|
Kolkata AIDS care centre project shelved after protests
|
Migration to cities causes blood pressure: study
|
Gulzar writes, Shaan sings for music video on AIDS
|
Assam on alert after bird flu spreads to new areas
|
Trust net of marriage makes women vulnerable to HIV: experts
|
Bhopal gas tragedy: 24 years on, the trauma continues
|
Now, disabled-friendly Agra eases Taj experience
|
| | Special Topics |
3,000 Kerala medical students to attend inter-college meet
|
Tamil Nadu seeks to control deemed universities
|
Spiders which eat together, stay together and multiply
|
Anna Hazare - the keeper of the earth and human conscience
|
Indian American scientist wins top IMO prize
|
Artificial human sperm could make men redundant: experts
|
Will autopsy on Benazir's body become necessary?
|
Murders in 'fit of passion' don't deserve death: Apex court
|
Low literacy equals early death sentence
|
New Insights Into the Nature of Pride as a Social Function
|
|
|
